Cota Healthcare announced the signing of a multi-year collaboration with Novartis Pharmaceuticals Corp. to help improve clinical and cost outcomes for breast cancer patients.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
